Literature DB >> 20331375

Usefulness of the Trendelenburg test for identification of patients with hip joint osteoarthritis.

James W Youdas1, Timothy J Madson, John H Hollman.   

Abstract

Abstract This study examined validity indices of the Trendelenburg test as a measure of hip abductor muscle performance (adduction of pelvis-on-femur [P-O-F]) when identifying subjects with and without hip joint osteoarthritis (OA). Muscle performance of the hip abductor muscles was obtained in standing by using the P-O-F position measured with a goniometer and in supine using a handheld dynamometer (HHD) and a manual muscle test (MMT). We studied 20 healthy adults (10 men and 10 women) and 20 adults (10 men and 10 women) with radiographically documented hip joint OA. Indices including sensitivity, specificity, and positive likelihood ratios examined values obtained from the P-O-F position and the MMT when used to identify subjects with and without hip joint OA. Sensitivity of the P-O-F position for identifying subjects with hip joint OA was 0.55, and specificity was 0.70, yielding a positive likelihood ratio of 1.83. Sensitivity of normalized hip abductor MMT strength for identifying subjects with hip joint OA was 0.35 and specificity was 0.90, yielding a positive likelihood ratio of 3.5. Based on validity information from the present study, the Trendelenburg test (P-O-F angle) is not useful in identifying subjects in the early stages of hip joint OA.

Entities:  

Mesh:

Year:  2010        PMID: 20331375     DOI: 10.3109/09593980902750857

Source DB:  PubMed          Journal:  Physiother Theory Pract        ISSN: 0959-3985            Impact factor:   2.279


  9 in total

1.  Clinical examination and physical assessment of hip joint-related pain in athletes.

Authors:  Michael P Reiman; Kristian Thorborg
Journal:  Int J Sports Phys Ther       Date:  2014-11

2.  Clinical utility of the Trendelenburg Test in people with multiple sclerosis.

Authors:  Paul W Kline; Cory L Christiansen; Dana L Judd; Mark M Mañago
Journal:  Physiother Theory Pract       Date:  2022-01-24       Impact factor: 2.176

3.  Great trochanter bursitis vs sciatica, a diagnostic-anatomic trap: differential diagnosis and brief review of the literature.

Authors:  Aristeidis H Zibis; Vasileios D Mitrousias; Michail E Klontzas; Theofilos Karachalios; Sokratis E Varitimidis; Apostolos H Karantanas; Dimitrios L Arvanitis
Journal:  Eur Spine J       Date:  2018-02-01       Impact factor: 3.134

4.  Perioperative platelet rich plasma (PRP) in total hip arthroplasty through the Hardinge approach: protocol to study the effectiveness for gluteus medius healing.

Authors:  Anni Aavikko; J Puhakka; J Haapala; J Kukkonen; K Mäkelä; J Kosola
Journal:  J Exp Orthop       Date:  2018-06-19

Review 5.  Does low back pain or leg pain in gluteus medius syndrome contribute to lumbar degenerative disease and hip osteoarthritis and vice versa? A literature review.

Authors:  Masahiro Kameda; Hideyuki Tanimae; Akinori Kihara; Fujio Matsumoto
Journal:  J Phys Ther Sci       Date:  2020-02-14

6.  Disability and functioning in primary and secondary hip osteoarthritis in Benin.

Authors:  Todègnon F Assogba; Didier D Niama-Natta; Toussaint G Kpadonou; Teefany Lawson; Philippe Mahaudens; Christine Detrembleur
Journal:  Afr J Disabil       Date:  2020-11-12

Review 7.  Chronic hip pain in adults: Current knowledge and future prospective.

Authors:  Vanita Ahuja; Deepak Thapa; Sofia Patial; Anjuman Chander; Anupam Ahuja
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2020-09-26

8.  Effects of incorporating elliptical trainer exercise during rehabilitation on physical function and self-reported outcomes after total hip arthroplasty: a randomized controlled trial.

Authors:  Yuki Hasebe; Kiyokazu Akasaka; Takahiro Otsudo; Toby Hall; Mitsuru Yamamoto
Journal:  J Phys Ther Sci       Date:  2022-03-14

9.  Effectiveness of a structured circuit class therapy model in stroke rehabilitation: a protocol for a randomised controlled trial.

Authors:  Isa U Lawal; Susan L Hillier; Talhatu K Hamzat; Anthea Rhoda
Journal:  BMC Neurol       Date:  2015-06-10       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.